Ontology type: schema:Chapter
2015
AUTHORSDave Li , Shinji Satomura
ABSTRACTThe past decades have witnessed increased use of biomarkers in disease management. A biomarker is any characteristic that can be objectively measured and evaluated as an indicator of normal biological process, pathogenic process, or pharmacological response to a therapeutic intervention. The clinical measurements of biomarkers can be carried out in vivo using imaging modalities like ultrasound (US), computed tomography (CT), and magnetic resonance imaging (MRI), as well as in vitro utilizing serum or plasma or other body fluids as specimens. In contrast to the imaging modalities, a prominent value of serum biomarkers is that they could be biologically relevant and disease-specific to pathophysiologic or pathologic process of disease development. This article provides an update of serum biomarkers for hepatocellular carcinoma (HCC) in risk assessment for early detection through surveillance. More... »
PAGES179-193
Advances in Cancer Biomarkers
ISBN
978-94-017-7214-3
978-94-017-7215-0
http://scigraph.springernature.com/pub.10.1007/978-94-017-7215-0_12
DOIhttp://dx.doi.org/10.1007/978-94-017-7215-0_12
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1045258061
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/26530367
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Biomarkers, Tumor",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Carcinoma, Hepatocellular",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Early Detection of Cancer",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Glycosylation",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Liver Neoplasms",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Risk Assessment",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Wako Life Sciences, Inc., 94043, Mountain View, CA, USA",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Wako Life Sciences, Inc., 94043, Mountain View, CA, USA"
],
"type": "Organization"
},
"familyName": "Li",
"givenName": "Dave",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Wako Life Sciences, Inc., 94043, Mountain View, CA, USA",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Wako Life Sciences, Inc., 94043, Mountain View, CA, USA"
],
"type": "Organization"
},
"familyName": "Satomura",
"givenName": "Shinji",
"id": "sg:person.01010774023.01",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01010774023.01"
],
"type": "Person"
}
],
"datePublished": "2015",
"datePublishedReg": "2015-01-01",
"description": "The past decades have witnessed increased use of biomarkers in disease management. A biomarker is any characteristic that can be objectively measured and evaluated as an indicator of normal biological process, pathogenic process, or pharmacological response to a therapeutic intervention. The clinical measurements of biomarkers can be carried out in vivo using imaging modalities like ultrasound (US), computed tomography (CT), and magnetic resonance imaging (MRI), as well as in vitro utilizing serum or plasma or other body fluids as specimens. In contrast to the imaging modalities, a prominent value of serum biomarkers is that they could be biologically relevant and disease-specific to pathophysiologic or pathologic process of disease development. This article provides an update of serum biomarkers for hepatocellular carcinoma (HCC) in risk assessment for early detection through surveillance.",
"editor": [
{
"familyName": "Scatena",
"givenName": "Roberto",
"type": "Person"
}
],
"genre": "chapter",
"id": "sg:pub.10.1007/978-94-017-7215-0_12",
"inLanguage": "en",
"isAccessibleForFree": false,
"isPartOf": {
"isbn": [
"978-94-017-7214-3",
"978-94-017-7215-0"
],
"name": "Advances in Cancer Biomarkers",
"type": "Book"
},
"keywords": [
"hepatocellular carcinoma",
"magnetic resonance imaging",
"serum biomarkers",
"use of biomarkers",
"pharmacological response",
"pathologic processes",
"therapeutic intervention",
"resonance imaging",
"pathogenic processes",
"clinical measurements",
"early detection",
"biomarkers",
"disease management",
"carcinoma",
"disease development",
"normal biological processes",
"ultrasound",
"modalities",
"body fluids",
"risk assessment",
"serum",
"intervention",
"tomography",
"vitro",
"vivo",
"surveillance",
"update",
"past decade",
"imaging",
"response",
"assessment",
"management",
"plasma",
"specimens",
"biological processes",
"contrast",
"fluid",
"use",
"indicators",
"prominent value",
"development",
"detection",
"decades",
"values",
"article",
"measurements",
"process"
],
"name": "Biomarkers for Hepatocellular Carcinoma (HCC): An Update",
"pagination": "179-193",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1045258061"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/978-94-017-7215-0_12"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"26530367"
]
}
],
"publisher": {
"name": "Springer Nature",
"type": "Organisation"
},
"sameAs": [
"https://doi.org/10.1007/978-94-017-7215-0_12",
"https://app.dimensions.ai/details/publication/pub.1045258061"
],
"sdDataset": "chapters",
"sdDatePublished": "2022-05-20T07:48",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/chapter/chapter_411.jsonl",
"type": "Chapter",
"url": "https://doi.org/10.1007/978-94-017-7215-0_12"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-94-017-7215-0_12'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-94-017-7215-0_12'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-94-017-7215-0_12'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-94-017-7215-0_12'
This table displays all metadata directly associated to this object as RDF triples.
141 TRIPLES
23 PREDICATES
80 URIs
74 LITERALS
15 BLANK NODES